Global Small Molecule Targeted Cancer Therapy Market Size study, and Regional Forecasts 2022-2032

by Type (Small Molecule Drug Conjugates, Small Molecules (Small Molecule Cyclin-Dependent Kinase Inhibitor, Small Molecule Proteasome Inhibitor, Small Molecule Tyrosine Kinase Inhibitor)), by Monoclonal Antibodies (Fully Human Antibody, Chimeric Monoclonal Antibody, Humanized Monoclonal Antibody) and

Published	Pages	Publisher	Report code
May 2025	285	Bizwit Research	ASDR-676476

Published: May 2025 - Pages : 285 - Publisher : Bizwit Research - Report code : ASDR-676476

• Pfizer Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca plc
• F. Hoffmann-La Roche Ltd
• Amgen Inc.
• Eli Lilly and Company
• Merck & Co. Inc.
• AbbVie Inc.
• Johnson & Johnson
• Bayer AG
• Takeda Pharmaceutical Company Limited
• Daiichi Sankyo Company
Limited
• Exelixis Inc.
• Seagen Inc.

Cancer Biological Therapy Market Size

This report can be of interest as well:

Cancer Biological Therapy Market Size

Published: July, 2021 | Report code: ASDR-604484